ABCG2 rs7756992: Understanding Your Genetic Variant
The rs7756992 variant is a regulatory single nucleotide polymorphism located within the ABCG2 gene. It is associated with variations in the expression of the ABCG2 transporter, which may influence systemic exposure to certain medications like statins and impact the risk of hyperuricemia.
What each genotype means
Typical transporter expression
This genotype represents the most common version of the ABCG2 gene in many populations. Research suggests this version is associated with standard function of the ABCG2 transporter protein, which helps regulate urate levels in the body. If you have questions about how your genetics might influence your health or medication response, please discuss them with your clinician or pharmacist.
This is the most common genotype globally, though frequencies vary significantly by ancestry.
Intermediate transporter expression
Carrying one copy of the T allele may be associated with subtle differences in how the ABCG2 transporter functions compared to the CC genotype. Some studies suggest that variations in this gene can influence urate excretion and potentially affect how the body processes certain medications, though the evidence for this specific variant remains limited. Please consult with your healthcare provider or a pharmacist regarding any concerns about medication dosing or metabolic health.
This heterozygous genotype is common across many global populations.
Altered transporter expression
This genotype is associated with a potential reduction in the efficiency of the ABCG2 transporter protein. Because this protein is involved in the excretion of urate, some research links this genetic profile to an increased risk of hyperuricemia or gout in certain populations. As the clinical impact of this variant can be influenced by other factors, please discuss these findings with your doctor to determine if they are relevant to your personal health history.
This genotype is less common than the CC or CT profiles but is found at varying frequencies across global populations.
What is rs7756992?
The rs7756992 variant is a specific change in the DNA sequence located within the ABCG2 gene, which resides on chromosome 4. In genetics, a single nucleotide polymorphism (SNP) like rs7756992 represents a variation at a single position in the genome. This particular variant is categorized as a regulatory SNP, meaning it is thought to influence how the ABCG2 gene is turned on or off, rather than necessarily changing the structure of the protein itself. Because it sits in a regulatory region, it can affect the total amount of transporter protein produced by cells. Researchers study these variants to understand how subtle differences in our genetic code contribute to the diversity of human physiological responses, particularly in how our bodies process substances like uric acid or pharmaceutical drugs.
The Role of the ABCG2 Gene
The ABCG2 gene provides instructions for making a protein called the ATP-binding cassette sub-family G member 2, also known as the Breast Cancer Resistance Protein (BCRP). This protein functions as an efflux transporter, acting like a molecular pump that moves various molecules out of cells and into the extracellular space. It is expressed in critical tissues throughout the body, including the liver, the intestines, and the blood-brain barrier. By pumping substances out of cells, the ABCG2 transporter plays a vital role in the body's ability to eliminate waste products, such as uric acid, and to regulate the absorption and clearance of many medications. When the expression or function of this transporter is altered, it can lead to changes in the concentration of these substances within the blood, potentially affecting health outcomes or drug efficacy.
Research and Evidence Strength
Current research into rs7756992 is categorized as having limited evidence regarding its direct clinical impact compared to more well-studied variants in the same gene, such as the Q141K (rs2231142) variant. Studies have observed associations between regulatory variants in ABCG2 and differences in statin exposure, as the transporter is involved in the pharmacokinetics of these cholesterol-lowering drugs. Additionally, because ABCG2 is a primary transporter for uric acid, variants that reduce its expression are often investigated for their link to hyperuricemia and gout risk. However, it is important to note that the evidence for rs7756992 specifically is still evolving. While statistical associations have been identified in various cohorts, the functional consequences can be complex and may depend on other genetic and environmental factors. As with all pharmacogenomic markers, these findings represent population-level trends rather than individual predictions.
Navigating Your Genetic Information
Understanding your genotype for rs7756992 can be an interesting part of your health journey, but it is essential to interpret this information correctly. Genetic variants are only one piece of a much larger puzzle that includes your diet, lifestyle, other medications, and overall health history. You cannot use this information to diagnose yourself with a condition or to make independent decisions about your medication dosages. If you are concerned about how your body processes statins or if you have questions about your risk for hyperuricemia, the most important step is to consult with your healthcare provider or a clinical pharmacist. They can integrate your genetic data with your clinical profile to provide personalized guidance. Always discuss any changes to your treatment plan with a professional, as they are best equipped to weigh the benefits and risks based on your unique medical needs.
How common is this variant?
The rs7756992 variant is common across global populations, with a minor allele frequency typically ranging between 0.3 and 0.5 depending on the specific ancestral group.
Frequently asked questions
What does it mean if I have the rs7756992 variant?
Having this variant simply means you have a specific DNA change that may influence the expression of the ABCG2 transporter. It is a common genetic variation and does not mean you have a disease or will definitely experience side effects from medication.
Does this variant cause gout?
While ABCG2 variants are linked to uric acid levels and gout risk, rs7756992 is a regulatory variant with limited evidence regarding its direct impact. Gout is a complex condition influenced by many genetic and lifestyle factors, not just a single SNP.
Should I change my statin dose based on this result?
No, you should never change your medication dosage based on genetic test results alone. Always consult your doctor or pharmacist, who can evaluate your entire health profile before making any adjustments to your treatment.
Is this variant the same as the ABCG2 Q141K variant?
No, rs7756992 is a different variant from the well-known Q141K (rs2231142) variant. While both are in the ABCG2 gene, they are distinct genetic markers with different levels of research and clinical evidence.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7756992?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCG2
Common regulatory non-coding variant frequently analyzed alongside Q141K for ABCG2-mediated transport capacity.
A premature stop codon polymorphism (p.Gln126Ter) in ABCG2 that causes non-functional transporter activity, increasing rosuvastatin plasma concentrations.
A major genetic driver of high uric acid and risk of gout.